Atlas Trials

PK and PD Study of Natalizumab in Pediatric Subjects With RRMS

Clinical trial NCT01884935 · COMPLETED

Trial details

NCT number
NCT01884935
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsing-Remitting Multiple Sclerosis
Start date
2013-07-01
Primary completion
2014-09-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.